Primary |
Conjunctivitis Allergic |
39.1% |
Conjunctivitis |
13.0% |
Rhinitis Allergic |
13.0% |
Eye Allergy |
8.7% |
Foreign Body Sensation In Eyes |
8.7% |
Keratitis |
8.7% |
Eye Discharge |
4.3% |
Photophobia |
4.3% |
|
Sneezing |
16.0% |
Shock |
12.0% |
Swelling Face |
12.0% |
Anaphylactoid Reaction |
8.0% |
Nasal Dryness |
8.0% |
Vomiting |
8.0% |
Anaphylactic Reaction |
4.0% |
Corneal Oedema |
4.0% |
Nasopharyngitis |
4.0% |
Peak Expiratory Flow Rate Decreased |
4.0% |
Stevens-johnson Syndrome |
4.0% |
Tremor |
4.0% |
Ulcerative Keratitis |
4.0% |
Vision Blurred |
4.0% |
Weight Decreased |
4.0% |
|
Secondary |
Cardiac Failure |
16.9% |
Hypersensitivity |
11.2% |
Conjunctivitis Allergic |
9.0% |
Seasonal Allergy |
9.0% |
Thrombosis Prophylaxis |
6.7% |
Eye Discharge |
4.5% |
Lacrimation Increased |
4.5% |
Atrial Fibrillation |
3.4% |
Back Pain |
3.4% |
Cardiac Failure Chronic |
3.4% |
Constipation |
3.4% |
Gastritis Prophylaxis |
3.4% |
Hyperuricaemia |
3.4% |
Insomnia |
3.4% |
Sleep Disorder |
3.4% |
Antiinflammatory Therapy |
2.2% |
Asthma |
2.2% |
Eye Allergy |
2.2% |
Glaucoma |
2.2% |
Pain |
2.2% |
|
Drug Ineffective |
19.0% |
Cerebral Infarction |
14.3% |
Musculoskeletal Chest Pain |
9.5% |
Oedema |
9.5% |
Contusion |
4.8% |
Drug Hypersensitivity |
4.8% |
Eye Pruritus |
4.8% |
Instillation Site Pain |
4.8% |
Muscle Spasms |
4.8% |
Myalgia |
4.8% |
Ocular Hyperaemia |
4.8% |
Pharmaceutical Product Complaint |
4.8% |
Rash |
4.8% |
Type V Hyperlipidaemia |
4.8% |
|
Concomitant |
Drug Use For Unknown Indication |
21.6% |
Product Used For Unknown Indication |
17.4% |
Hypersensitivity |
7.0% |
Asthma |
6.2% |
Hypertension |
6.0% |
Pain |
5.4% |
Rheumatoid Arthritis |
4.0% |
Multiple Allergies |
3.8% |
Osteoporosis |
3.6% |
Depression |
3.0% |
Gastrooesophageal Reflux Disease |
2.9% |
Insomnia |
2.8% |
Rhinitis Allergic |
2.7% |
Diabetes Mellitus |
2.3% |
Migraine |
2.1% |
Seasonal Allergy |
2.0% |
Arthritis |
1.8% |
Fibromyalgia |
1.8% |
Prophylaxis |
1.7% |
Anxiety |
1.7% |
|
Vomiting |
15.9% |
Weight Increased |
10.6% |
Weight Decreased |
9.8% |
Pain |
5.7% |
Pulmonary Embolism |
5.3% |
White Blood Cell Count Increased |
5.3% |
Wheezing |
4.9% |
Urinary Tract Infection |
4.5% |
Dyspnoea |
4.1% |
Visual Acuity Reduced |
4.1% |
Drug Ineffective |
3.7% |
Urticaria |
3.7% |
Headache |
3.3% |
Death |
2.9% |
Myalgia |
2.9% |
Nausea |
2.9% |
Syncope |
2.9% |
Tremor |
2.9% |
Abdominal Pain |
2.4% |
Cholecystitis Chronic |
2.4% |
|